Signaling Pathways - G9a - AP-1 - Urokinases - RET
清除全部
- B7757 UNC 0642Target: G9a|GLPSummary: G9a和GLP组蛋白赖氨酸甲基转移酶抑制剂
- B4664 T-522410 CitationTarget: AP-1|MMPSummary: C-Fos/AP-1抑制剂
- B2268 Amiloride HCl dihydrate中文名: 盐酸阿米洛利二水合物Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|UrokinasesSummary: 有效上皮钠通道(ENaC)阻断剂
- A2174 Lenvatinib (E7080)中文名: 乐伐替尼,仑伐替尼Target: VEGFR|PDGFR|RETSummary: VEGFR抑制剂
- A8236 Regorafenib4 Citation中文名: 瑞戈非尼Target: Raf|VEGFR|PDGFR|c-Kit|RETSummary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
- A4445 4-Chlorophenylguanidine hydrochlorideTarget: UrokinasesSummary: 尿激酶(urokinase)抑制剂
- A3194 AST 4871 CitationTarget: RETSummary: RET激酶抑制剂
- A1909 BIX 01294Target: G9aSummary: G9a和GLP抑制剂
- A4130 ENMD-2076Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-FmsSummary: Aurora A/Flt3的选择性抑制剂
- N1846 Tanshinone IIA中文名: 丹参酮IIATarget: AP-1|MAGLSummary: 抗氧化和抗炎剂